Dr. Joan H. Schiller is former Division Chief of Hematology/Oncology at The University of Texas Southwestern Medical Center, where she led the institution's process to become a National Cancer Institute (NCI)-designated cancer center and then an NCI-designated comprehensive center in 2015, and former Deputy Director of the Simmons Comprehensive Cancer Center in Dallas.
Dr. Schiller is widely published and internationally recognized for her work in lung cancer clinical research. She has served as chairperson of the Thoracic Oncology Committee of the Eastern Co-operative Oncology Group; an editor for the Journal of Clinical Oncology; a board member for the International Association for the Study of Lung Cancer, and the principal investigator on many Phase I, II and III clinical trials for lung cancer. Dr. Schiller currently serves on the NCI Board of Scientific Counselors - Clinical Sciences and Epidemiology. She also serves on ASCO’s Guideline Panel for Systemic Therapy for Stage IV Non-small Cell Lung Cancer and is a mentor for ASCO's Leadership Development Program.
Before serving as the Deputy Director of Clinical Investigation for the Inova Schar Cancer Institute in Fairfax, Virginia, and Chief of Hematology/Oncology, she was the division chief of Hematology/Oncology at the University of Texas-Southwestern Medical Center and Deputy Director of the Simmons Comprehensive Cancer Center in Dallas, where she held the Andrea L. Simmons Distinguished Chair in Cancer Research.
Dr. Schiller graduated from the University of Illinois Medical School and completed her internship and residency in internal medicine at Northwestern Memorial Hospital in Chicago. She then completed a clinical fellowship in the Department of Human Oncology at the University of Wisconsin Comprehensive Cancer Center where she became the Melanie Heald Professor in the Department of Medicine, Section of Medical Oncology, and subsequently served as head of the Lung Cancer Program at the University of Wisconsin Comprehensive Cancer Center.
Dr. Schiller’s research has generated well over 200 publications that she has authored or co-authored, including articles, abstracts, book chapters, books, reviews, and invited manuscripts.
Dr. Schiller is also the founder and President of Free to Breathe, a national advocacy organization aimed at raising awareness and funding for lung cancer, which has recently merged with Lung Cancer Research Foundation.
For more information visit:
https://www.lungcancerresearchfoundation.org/dr-schiller-iaslc-scientif…
https://ascopost.com/issues/february-25-2021/paul-a-bunn-jr-scientific-…
https://www.iaslc.org/iaslc-news/lung-cancer-considered/conversation-me…
https://www.thoracic.org/patients/par/awards/jschiller.php
None
Forum Discussions
There is not a ton of info available for Cholangiocarcinoma, so seeing information come up with new developments is always exciting. In this video, Rachna Shroff MD, chief of Gastrointestinal Medical
Hi all -- share your cancer journey here and connect with others. Cancer.gov has a good general description of Cholangiocarcinoma. This rare disease has support information and programs that can be
Keep your eye out for new Head and Neck information soon!
Gallbladder Cancer is a rare disease in which malignant cells form in the tissues of the gallbladder. Bile duct cancer or cholangiocarcinoma is a rare disease in which malignant cells form in the
The happiest of Thanksgiving to everyone! Thank you for being a part of GRACE!
Comments
I agree that not all docs are good communicators! Remember they are people just like us, filling a
Our friend and past participant Melinda Bachini shared with us some information on her clinical
It is so good to hear from you, and my sentiments are the same as Janine's. You are definitely why
You may find our clinical trial page helpful, also. https://cancergrace.org/find-clinical-trials.